Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Sihuan Pharma to Invest $208 Million in Tonghua City Facilities

publication date: Jan 5, 2011
Sihuan Pharmaceutical Holdings Group reached an agreement with Tonghua City, Jilin Province to invest 1.375 billion RMB ($208 million) in the area over the next few years. The company will locate its northern headquarters in Tonghua, plus build an R&D facility and a manufacturing plant in the city’s life science park. Tonghua is seeking pharma investment as it strives to become “China Medical City.” More details....

Stock Symbol: (HKEX: 0460)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital